Latest

Claire Phipps-Jones, Amy Howlett (Bristows)

The Council and Parliament agree on the EU Pharma Package: dilution of enforcement rights in the UPC arising from the expanded Bolar exemption?

December 11, 2025

BackgroundWe previously set out the background and genesis of the proposed regulatory provisions of the "Proposal for a Directive of the European Parliament and of the Council on the Union Code…

Articles

Enjoy new articles covering various topics every day. If you would like to join our authors and gain recognition in a legal world contact Editorial Guidelines.

Joana Piriquito Santos (NLP Law firm)

EU Biotech Act: The Coming EU IP Shake-Up?

December 10, 2025

It is increasingly difficult to discuss Intellectual Property (IP) without immediately bumping into questions of Artificial Intelligence (AI). The EU has been busy legislating in this field in recent…

Matthieu Dhenne (Dhenne Avocats)

Pay-for-Delay: The CJEU Confirms Teva/Cephalon and Defines the Limits of Patent Settlement Agreements

December 9, 2025

An offer you can refuse?The recent judgment in Teva/Cephalon firmly anchors EU jurisprudence on pay-for-delay agreements. By upholding the sanctions imposed on the two companies for a series of side…

John Collins, Kent Teague, Emina Besirevic (Clayton Utz)

Full Federal Court abolishes patent term extensions for pharmaceutical formulations

December 8, 2025

In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions (PTE): Otsuka…

Gregory Bacon, Eden Winlow (Bristows)

UPC Christmas Quiz 2025

December 3, 2025

As we celebrate another year of the Unified Patent Court in action and head into the festive season, we invite our readers to put their UPC knowledge to the test in the Kluwer UPC Christmas Quiz 2025…

Rob Rodrigues (RNA Law)

Brazil: An Unregulated “Pharmaceutical Orange Book”? New patent-intelligence cooperation has a story to tell

December 1, 2025

Brazil’s Ministry of Health and ABIFINA, the association representing local biosimilar and generic companies, have signed a patent-intelligence cooperation agreement aimed at improving the use of…

Matthieu Dhenne (Dhenne Avocats)

Merz v. Viatris: Why Urgency Matters in UPC Pharma Injunctions

November 26, 2025

The UPC Paris Local Division has just released its much-anticipated decision in Merz v. Viatris, which at first glance looks like a familiar pharmaceutical case. A generic product moves through the…